News | Published:

Migraine drug race turns its final corner, FDA decisions in sight

Nature Biotechnology volume 36, pages 207208 (2018) | Download Citation

Subjects

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from $8.99

All prices are NET prices.

Author information

Affiliations

  1. Somerville, Massachusetts

    • Elie Dolgin

Authors

  1. Search for Elie Dolgin in:

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt0318-207